Bandingkan Harga & Kinerja Intikeramik Alamasri Industri Tbk. (IKAI) vs UBC Medical Indonesia Tbk. (LABS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Intikeramik Alamasri Industri Tbk. dan UBC Medical Indonesia Tbk.: Intikeramik Alamasri Industri Tbk. diperdagangkan di Rp21 (kapitalisasi pasar 279,42 M, volume 24 jam 9,17 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp165 (kapitalisasi pasar 635,95 M, volume 24 jam 843 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 2,3× kapitalisasi pasar Intikeramik Alamasri Industri Tbk., dan Intikeramik Alamasri Industri Tbk. lebih aktif diperdagangkan (9,17 jt vs 843 rb). Mana yang lebih baik tergantung tujuan investasimu.
| IKAI | LABS | |
|---|---|---|
Kapitalisasi Pasar | 279,42 M | 635,95 M |
Volume | 9,17 jt | 843 rb |
Lot | 91,73 rb | 8,43 rb |
Perputaran | 189,5 jt | 137,6 jt |
Harga Rata-rata | 20,66 | 163,22 |
Nilai Transaksi | 189,5 jt | 137,6 jt |
Harga Ekuilibrium Indikatif | 21 | 165 |
Volume Ekuilibrium Indikatif | 21,35 rb | 246 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Intikeramik Alamasri Industri Tbk.
PT Intikeramik Alamasri Industri Tbk (the Company) was established under the name PT Intikeramik Alamasri Indah based on notarial deed No. 38 dated June 26, 1991 and was amended with notarial deed No. 16 dated December 14, 1991, both made by Raden Muhammad Hendarmawan, S.H., Notary in Jakarta. PT Intikeramik Alamasri Industri Tbk is the pioneer of large-scale porcelain tile manufacture in Indonesia and one of the largest producers in the Asia Pacific region. Porcelain tiles are superior in term of strength, durability and design versatility to natural stone as well as other synthetics such as glazed tiles. Porcelain is attractive and affordable for use in both commercial and residential developments and has strong following among international architects and interior designers. Intikeramik is seeking to build a leading profile in markets across Europe, America and Asia drawing upon its reputation for consistency, advanced manufacturing technology, a low cost base and substantial available capacity. The company has consolidation production capacity 6,600,000 m2 /year.
Selengkapnya di halaman IKAI →Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
